{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:17:57Z","timestamp":1794917877195,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["A2020301"],"award-info":[{"award-number":["A2020301"]}],"id":[{"id":"10.13039\/http:\/\/dx.doi.org\/10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dongguan social science and technology development foundation","award":["202050715025188"],"award-info":[{"award-number":["202050715025188"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mater Sci: Mater Med"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Poly-L-lactic acid (PLLA) is considered to be a promising candidate material for biodegradable vascular scaffolds (BVS) in percutaneous coronary intervention (PCI). But, PLLA-BVS also faces the challenge of thrombosis (ST) and in-stent restenosis (ISR) caused by in-stent neo-atherosclerosis (ISNA) associated with inflammatory reactions in macrophage-derived foam cells. Our previous studies have confirmed that curcumin alleviates PLLA-induced injury and inflammation in vascular endothelial cells, but it remains unclear whether curcumin can alleviate the effect of inflammatory reactions in macrophage-derived foam cells while treated with degraded product of PLLA. In this study, PLLA-BVS was implanted in the porcine coronary artery to examine increased macrophages and inflammatory cytokines such as NF-\u03bab and TNF-\u03b1 by histology and immunohistochemistry. In vitro, macrophage-derived foam cells were induced by Ox-LDL and observed by Oil Red Staining. Foam cells were treated with pre-degraded PLLA powder, curcumin and PPAR\u03b3 inhibitor GW9662, and the expression of IL-6, IL-10, TNF-\u03b1, NF-\u03bab, PLA2 and PPAR\u03b3 were investigated by ELISA or RT-qPCR. This study demonstrated that the macrophages and inflammatory factors increased after PLLA-BVS implantation in vivo, and foam cells derived from macrophages promoted inflammation by products of PLLA degradation in vitro. This present study was found that the inflammation of foam cells at the microenvironment of PLLA degraded products were significantly increased, and curcumin can attenuate the inflammation caused by the PLLA degradation via PPAR\u03b3 signal pathway. In addition, curcumin should be further studied experimentally in vivo experiments on animal models as a potential therapeutic to reduce ISNA of PLLA-BVS.<\/jats:p>","DOI":"10.1007\/s10856-022-06654-7","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T08:04:53Z","timestamp":1647590693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Curcumin attenuates inflammation of Macrophage-derived foam cells treated with Poly-L-lactic acid degradation via PPAR\u03b3 signaling pathway"],"prefix":"10.1007","volume":"33","author":[{"given":"Dongping","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangbo","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linsheng","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7250-2734","authenticated-orcid":false,"given":"Jianmin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"key":"6654_CR1","unstructured":"WHO. Cardiovascular diseases (CVDs). 2021. https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds). Accessed 11 June 2021."},{"key":"6654_CR2","doi-asserted-by":"publisher","unstructured":"Gaba P, Gersh BJ, Ali ZA, Moses JW, Stone GW. Complete versus incomplete coronary revascularization: definitions, assessment and outcomes. NAT REV CARDIOL. 2021; https:\/\/doi.org\/10.1038\/s41569-020-00457-5","DOI":"10.1038\/s41569-020-00457-5"},{"key":"6654_CR3","doi-asserted-by":"publisher","unstructured":"Verdoia M, Kedhi E, Suryapranata H, Galasso G, Dudek D, De Luca G. Poly (l-lactic acid) bioresorbable scaffolds versus metallic drug-eluting stents for the treatment of coronary artery disease: A meta-analysis of 11 randomized trials. Catheter Cardiovasc Interv. 2020; https:\/\/doi.org\/10.1002\/ccd.28594","DOI":"10.1002\/ccd.28594"},{"key":"6654_CR4","doi-asserted-by":"publisher","unstructured":"Peng X, Qu W, Jia Y, Wang Y, Yu B, Tian J. Bioresorbable Scaffolds: Contemporary Status and Future Directions. Front Cardiovasc Med. 2020; https:\/\/doi.org\/10.3389\/fcvm.2020.589571","DOI":"10.3389\/fcvm.2020.589571"},{"key":"6654_CR5","doi-asserted-by":"publisher","unstructured":"Wykrzykowska JJ, Kraak RP, Hofma SH, van der Schaaf RJ, Arkenbout EK, IJsselmuiden AJ, et al. Bioresorbable Scaffolds versus Metallic Stents in Routine PCI. N Engl J Med. 2017; https:\/\/doi.org\/10.1056\/NEJMoa1614954","DOI":"10.1056\/NEJMoa1614954"},{"key":"6654_CR6","doi-asserted-by":"publisher","unstructured":"Borovac JA, D\u2019Amario D, Vergallo R, Porto I, Bisignani A, Galli M, et al. Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge. Eur Heart J Cardiovasc Pharmacother. 2019; https:\/\/doi.org\/10.1093\/ehjcvp\/pvy036","DOI":"10.1093\/ehjcvp\/pvy036"},{"key":"6654_CR7","doi-asserted-by":"publisher","unstructured":"Moriyama N, Shishido K, Tanaka Y, Laine M, Saito S. Neoatherosclerosis- Long-Term Assessment of Bioresorbable Vascular Scaffold. Circ Rep. 2019; https:\/\/doi.org\/10.1253\/circrep.CR-19-0100","DOI":"10.1253\/circrep.CR-19-0100"},{"key":"6654_CR8","doi-asserted-by":"publisher","unstructured":"Hiltrop N, Desmet W, Adriaenssens T, Bennett J. Neoatherosclerosis: an emerging and conceptually unexpected cause of very late bioresorbable vascular scaffold failure. Eurointervention. 2017; https:\/\/doi.org\/10.4244\/EIJ-D-16-00259","DOI":"10.4244\/EIJ-D-16-00259"},{"key":"6654_CR9","doi-asserted-by":"publisher","unstructured":"Kang SH, Kang SJ, Kim WJ. Neoatherosclerosis as the Cause of Late Failure of a Bioresorbable Vascular Scaffold at 8 Months. JACC Cardiovasc Interv. 2017; https:\/\/doi.org\/10.1016\/j.jcin.2017.07.018","DOI":"10.1016\/j.jcin.2017.07.018"},{"key":"6654_CR10","doi-asserted-by":"publisher","unstructured":"Mangiameli A, Ohno Y, Attizzani GF, Capodanno D, Tamburino C. Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold. JACC Cardiovasc Interv. 2015; https:\/\/doi.org\/10.1016\/j.jcin.2014.11.014","DOI":"10.1016\/j.jcin.2014.11.014"},{"key":"6654_CR11","doi-asserted-by":"publisher","unstructured":"Otsuka F, Byrne RA, Yahagi K, Mori H, Ladich E, Fowler DR, et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J. 2015; https:\/\/doi.org\/10.1093\/eurheartj\/ehv205","DOI":"10.1093\/eurheartj\/ehv205"},{"key":"6654_CR12","doi-asserted-by":"publisher","unstructured":"Moriyama N, Shishido K, Tanaka Y, Yokota S, Hayashi T, Miyashita H, et al. Neoatherosclerosis 5 years after bioresorbable vascular scaffold implantation. J Am Coll Cardiol. 2018; https:\/\/doi.org\/10.1016\/j.jacc.2018.02.051","DOI":"10.1016\/j.jacc.2018.02.051"},{"key":"6654_CR13","doi-asserted-by":"publisher","unstructured":"Onuma Y, Serruys PW, Perkins LE, Okamura T, Gonzalo N, Garcia-Garcia HM, et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial. Circulation. 2010; https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.921528","DOI":"10.1161\/CIRCULATIONAHA.109.921528"},{"key":"6654_CR14","doi-asserted-by":"publisher","unstructured":"Chen D, Dong Z, Xi Y, Chen C, Zhang S, Zeng S, et al. Long-Term Arterial remodeling after bioresorbable scaffold implantation 4-year follow-up of quantitative coronary Angiography, Histology and Optical Coherence Tomography. Cardiovasc Eng Technol. 2020; https:\/\/doi.org\/10.1007\/s13239020-00495-7","DOI":"10.1007\/s13239020-00495-7"},{"key":"6654_CR15","doi-asserted-by":"publisher","unstructured":"Amini AR, Wallace JS, Nukavarapu SP. Short-term and long-term effects of orthopedic biodegradable implants. J Long Term Eff Med Implants. 2011; https:\/\/doi.org\/10.1615\/jlongtermeffmedimplants.v21.i2.10","DOI":"10.1615\/jlongtermeffmedimplants.v21.i2.10"},{"key":"6654_CR16","doi-asserted-by":"publisher","unstructured":"Wang QS, Cui YL, Gao LN, Guo Y, Li RX, Zhang XZ. Reduction of the pro-inflammatory response by tetrandrine-loading poly(L-lactic acid) films in vitro and in vivo. J Biomed Mater Res A. 2014; https:\/\/doi.org\/10.1002\/jbm.a.35083","DOI":"10.1002\/jbm.a.35083"},{"key":"6654_CR17","doi-asserted-by":"publisher","unstructured":"Chen D, Weng L, Chen C, Zheng J, Wu T, Zeng S, et al. Inflammation and dysfunction in human aortic endothelial cells associated with poly-l-lactic acid degradation in vitro are alleviated by curcumin. J Biomed Mater Res A. 2019; https:\/\/doi.org\/10.1002\/jbm.a.36778","DOI":"10.1002\/jbm.a.36778"},{"key":"6654_CR18","doi-asserted-by":"publisher","unstructured":"Wang D, Yang Y, Lei Y, Tzvetkov NT, Liu X, Yeung A, et al. Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products. Pharmacol Rev. 2019; https:\/\/doi.org\/10.1124\/pr.118.017178","DOI":"10.1124\/pr.118.017178"},{"key":"6654_CR19","doi-asserted-by":"publisher","unstructured":"Liu X, Wu J, Tian R, Su S, Deng S, Meng X. Targeting foam cell formation and macrophage polarization in atherosclerosis: The Therapeutic potential of rhubarb. Biomed Pharmacother. 2020; https:\/\/doi.org\/10.1016\/j.biopha.2020.110433","DOI":"10.1016\/j.biopha.2020.110433"},{"key":"6654_CR20","doi-asserted-by":"publisher","unstructured":"Pei C, Zhang Y, Wang P, Zhang B, Fang L, Liu B, et al. Berberine alleviates oxidized low-density lipoprotein-induced macrophage activation by downregulating galectin-3 via the NF-kappaB and AMPK signaling pathways. Phytother Res. 2019; https:\/\/doi.org\/10.1002\/ptr.6217","DOI":"10.1002\/ptr.6217"},{"key":"6654_CR21","doi-asserted-by":"publisher","unstructured":"Cao J, Ye B, Lin L, Tian L, Yang H, Wang C, et al. Curcumin Alleviates oxLDL Induced MMP-9 and EMMPRIN Expression through the Inhibition of NF-kappaB and MAPK Pathways in Macrophages. Front Pharmacol. 2017; https:\/\/doi.org\/10.3389\/fphar.2017.00062","DOI":"10.3389\/fphar.2017.00062"},{"key":"6654_CR22","doi-asserted-by":"publisher","unstructured":"Mohammadian HS, Karimzadeh MR, Azhdari S, Vahedi P, Abdollahi E, Momtazi-Borojeni AA. Modulatory effects of curcumin on the atherogenic activities of inflammatory monocytes: Evidence from in vitro and animal models of human atherosclerosis. Biofactors. 2020; https:\/\/doi.org\/10.1002\/biof.1603","DOI":"10.1002\/biof.1603"},{"key":"6654_CR23","doi-asserted-by":"publisher","unstructured":"Momtazi-Borojeni AA, Abdollahi E, Nikfar B, Chaichian S, Ekhlasi-Hundrieser M. Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy. Heart Fail Rev. 2019; https:\/\/doi.org\/10.1007\/s10741-018-09764-z","DOI":"10.1007\/s10741-018-09764-z"},{"key":"6654_CR24","doi-asserted-by":"publisher","unstructured":"Zhang D, Yang Y, Li Y, Zhang G, Cheng Z. Inhibitory Effect of Curcumin on Artery Restenosis Following Carotid Endarterectomy and Its Associated Mechanism in vitro and in vivo. Drug Des Devel Ther. 2020; https:\/\/doi.org\/10.2147\/DDDT.S229607","DOI":"10.2147\/DDDT.S229607"},{"key":"6654_CR25","doi-asserted-by":"publisher","unstructured":"Mahmood K, Zia KM, Zuber M, Salman M, Anjum MN. Recent developments in curcumin and curcumin based polymeric materials for biomedical applications: A review. Int J Biol Macromol. 2015; https:\/\/doi.org\/10.1016\/j.ijbiomac.2015.09.026","DOI":"10.1016\/j.ijbiomac.2015.09.026"},{"key":"6654_CR26","doi-asserted-by":"publisher","unstructured":"Su SH, Nguyen KT, Satasiya P, Greilich PE, Tang L, Eberhart RC. Curcumin impregnation improves the mechanical properties and reduces the inflammatory response associated with poly(L-lactic acid) fiber. J Biomater Sci Polym Ed. 2005; https:\/\/doi.org\/10.1163\/1568562053654077","DOI":"10.1163\/1568562053654077"},{"key":"6654_CR27","doi-asserted-by":"publisher","unstructured":"Lan Z, Lyu Y, Xiao J, Zheng X, He S, Feng G, et al. Novel biodegradable drug-eluting stent composed of poly-L-lactic acid and amorphous calcium phosphate nanoparticles demonstrates improved structural and functional performance for coronary artery disease. J Biomed Nanotechnol. 2014; https:\/\/doi.org\/10.1166\/jbn.2014.1868","DOI":"10.1166\/jbn.2014.1868"},{"key":"6654_CR28","doi-asserted-by":"publisher","unstructured":"Li X, Guo D, Chen Y, Hu Y, Zhang F. Effects of Altered Levels of Pro- and Anti-Inflammatory Mediators on Locations of In-Stent Reocclusions in Elderly Patients. Mediators Inflamm. 2020; https:\/\/doi.org\/10.1155\/2020\/1719279","DOI":"10.1155\/2020\/1719279"},{"key":"6654_CR29","doi-asserted-by":"publisher","unstructured":"Wang X, Zachman AL, Chun YW, Shen FW, Hwang YS, Sung HJ. Polymeric stent materials dysregulate macrophage and endothelial cell functions: implications for coronary artery stent. Int J Cardiol. 2014; https:\/\/doi.org\/10.1016\/j.ijcard.2014.04.228","DOI":"10.1016\/j.ijcard.2014.04.228"},{"key":"6654_CR30","doi-asserted-by":"publisher","unstructured":"Bergsma EJ, Rozema FR, Bos RR, de Bruijn WC. Foreign body reactions to resorbable poly(L-lactide) bone plates and screws used for the fixation of unstable zygomatic fractures. J Oral Maxillofac Surg. 1993; https:\/\/doi.org\/10.1016\/s0278-2391(10)80267-8","DOI":"10.1016\/s0278-2391(10)80267-8"},{"key":"6654_CR31","doi-asserted-by":"publisher","unstructured":"Mazidi M, Karimi E, Meydani M, Ghayour-Mobarhan M, Ferns GA. Potential effects of curcumin on peroxisome proliferator-activated receptor-gamma in vitro and in vivo. World J Methodol. 2016; https:\/\/doi.org\/10.5662\/wjm.v6.i1.112","DOI":"10.5662\/wjm.v6.i1.112"},{"key":"6654_CR32","doi-asserted-by":"publisher","unstructured":"Hutchins PM, Heinecke JW. Cholesterol efflux capacity, macrophage reverse cholesterol transport and cardioprotective HDL. Curr Opin Lipidol. 2015; https:\/\/doi.org\/10.1097\/MOL.0000000000000209","DOI":"10.1097\/MOL.0000000000000209"},{"key":"6654_CR33","doi-asserted-by":"publisher","unstructured":"Chistiakov DA, Melnichenko AA, Myasoedova VA, Grechko AV, Orekhov AN. Mechanisms of foam cell formation in atherosclerosis. J Mol Med (Berl). 2017; https:\/\/doi.org\/10.1007\/s00109-017-1575-8","DOI":"10.1007\/s00109-017-1575-8"},{"key":"6654_CR34","doi-asserted-by":"publisher","unstructured":"Tselepis AF, Rizzo M, Goudevenos IA. Therapeutic modulation of lipoprotein-associated phospholipase A2 (Lp-PLA2). Curr Pharm Des. 2011; https:\/\/doi.org\/10.2174\/138161211798220936","DOI":"10.2174\/138161211798220936"},{"key":"6654_CR35","doi-asserted-by":"publisher","unstructured":"Daugherty A, Tall AR, Daemen M, Falk E, Fisher EA, Garcia-Cardena G, et al. Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies: A Scientific Statement From the American Heart Association. Arterioscler Thromb Vasc Biol. 2017; https:\/\/doi.org\/10.1161\/ATV.0000000000000062","DOI":"10.1161\/ATV.0000000000000062"},{"key":"6654_CR36","doi-asserted-by":"publisher","unstructured":"Poznyak AV, Wu WK, Melnichenko AA, Wetzker R, Sukhorukov V, Markin AM, et al. Signaling Pathways and Key Genes Involved in Regulation of foam Cell Formation in Atherosclerosis. Cells-Basel. 2020; https:\/\/doi.org\/10.3390\/cells9030584","DOI":"10.3390\/cells9030584"},{"key":"6654_CR37","doi-asserted-by":"publisher","unstructured":"Shakeri F, Boskabady MH. Anti-inflammatory, antioxidant, and immunomodulatory effects of curcumin in ovalbumin-sensitized rat. Biofactors. 2017; https:\/\/doi.org\/10.1002\/biof.1364","DOI":"10.1002\/biof.1364"},{"key":"6654_CR38","doi-asserted-by":"publisher","unstructured":"Kahkhaie KR, Mirhosseini A, Aliabadi A, Mohammadi A, Mousavi MJ, Haftcheshmeh SM, et al. Curcumin: a modulator of inflammatory signaling pathways in the immune system. Inflammopharmacology. 2019; https:\/\/doi.org\/10.1007\/s10787-019-00607-3","DOI":"10.1007\/s10787-019-00607-3"},{"key":"6654_CR39","doi-asserted-by":"publisher","unstructured":"Zhang HF, Wu MX, Lin YQ, Xie SL, Huang TC, Liu PM, et al. IL-33 promotes IL-10 production in macrophages: a role for IL-33 in macrophage foam cell formation. Exp Mol Med. 2017; https:\/\/doi.org\/10.1038\/emm.2017.183","DOI":"10.1038\/emm.2017.183"}],"container-title":["Journal of Materials Science: Materials in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-022-06654-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10856-022-06654-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-022-06654-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T06:22:23Z","timestamp":1650954143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10856-022-06654-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["6654"],"URL":"https:\/\/doi.org\/10.1007\/s10856-022-06654-7","relation":{},"ISSN":["1573-4838"],"issn-type":[{"value":"1573-4838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,18]]},"assertion":[{"value":"9 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"33"}}